The agrochemical and pharmaceutical company Bayer has also received a defeat in the third of its US appeal proceedings because of alleged cancer risks of the weed killer glyphosate.

The responsible court in San Francisco on Monday upheld a ruling that Bayer is liable for cancers suffered by plaintiffs Alberta and Alva Pilliod.

In 2019, a jury in California first sentenced the group to damages and fines of around two billion dollars to the couple.

The court later reduced the amount to $ 86.7 million.

A spokesman for Bayer said the company respected the court's decision but did not agree.

The judgment is not supported by the evidence at the trial or by applicable law.

The group is exploring its options for a re-examination of the case.

Follow the Monsanto takeover

Bayer had this and many other legal conflicts in 2018 with the over 60 billion dollar purchase of the American seed giant Monsanto.

Bayer is confronted with numerous other glyphosate lawsuits in the United States, which the company would actually like to settle with a major settlement.

Only three cases have so far been finally negotiated in US courts, and the Dax group lost all three processes.

Bayer has not had any success in appointment procedures either.

A fourth lawsuit against the group has recently started in California.

The Leverkusen-based company has high hopes that one of the rulings by the United States Supreme Court will be overturned.

In the event that the Supreme Court does not want to deal with the glyphosate case or decides against Bayer, the group recently set up additional provisions of $ 4.5 billion. Bayer had previously set aside more than $ 11 billion for a settlement package to settle US lawsuits.